Re-examining baseline lung function recovery following IV-treated pulmonary exacerbations
dc.contributor.author | Heltshe, Sonya L. | |
dc.contributor.author | Russell, Renee | |
dc.contributor.author | VanDevanter, Donald R. | |
dc.contributor.author | Sanders, Don B. | |
dc.contributor.department | Pediatrics, School of Medicine | |
dc.date.accessioned | 2024-11-01T10:29:16Z | |
dc.date.available | 2024-11-01T10:29:16Z | |
dc.date.issued | 2023 | |
dc.description.abstract | CF registry pulmonary exacerbation (PEx) analyses have employed "before and after" spirometry recovery, where the best percent predicted forced expiratory volume in 1 s (ppFEV1) prior to PEx ("baseline") is compared to the best ppFEV1 <3 months post-PEx. This methodology lacks comparators and ascribes recovery failure to PEx. Herein, we describe 2014 CF Foundation Patient Registry PEx analyses including a comparator: recovery around nonPEx events, birthdays. 49.6% of 7357 individuals with PEx achieved baseline ppFEV1 recovery while 36.6% of 14,141 achieved baseline recovery after birthdays; individuals with both PEx and birthdays were more likely to recover baseline after PEx than after birthdays (47% versus 34%); mean ppFEV1 declines were 0.3 (SD=9.3) and 3.1 (9.3), respectively. Post-event measure number had more effect on baseline recovery than did real ppFEV1 loss in simulations, suggesting that PEx recovery analyses lacking comparators are prone to artifact and poorly describe PEx contributions to disease progression. | |
dc.eprint.version | Author's manuscript | |
dc.identifier.citation | Heltshe SL, Russell R, VanDevanter DR, Sanders DB. Re-examining baseline lung function recovery following IV-treated pulmonary exacerbations. J Cyst Fibros. 2023;22(5):864-867. doi:10.1016/j.jcf.2023.02.006 | |
dc.identifier.uri | https://hdl.handle.net/1805/44412 | |
dc.language.iso | en_US | |
dc.publisher | Elsevier | |
dc.relation.isversionof | 10.1016/j.jcf.2023.02.006 | |
dc.relation.journal | Journal of Cystic Fibrosis | |
dc.rights | Publisher Policy | |
dc.source | PMC | |
dc.subject | Comparator | |
dc.subject | Cystic fibrosis | |
dc.subject | Outcomes | |
dc.subject | Patient registry | |
dc.subject | Pulmonary exacerbation | |
dc.title | Re-examining baseline lung function recovery following IV-treated pulmonary exacerbations | |
dc.type | Article |